Editas Medicine
Genome editing company dedicated to treating patients with genetically-defined diseases.
Based in MA
AI Overview
With $440K in lobbying spend across 10 quarterly filings, Editas Medicine is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2020.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $180K |
| 2019 | $200K |
| 2020 | $60K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Editas Medicine disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues
Issues related to reimbursement of novel therapies; monitored issue related to drug pricing.
Monitored issues related to the science of gene editing.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.